An implantable material designed to reinforce suture lines and/or increase the strength of weak or injured cardiac and/or peripheral vascular tissues during cardiovascular repair/reconstruction procedures (e.g., annulus or septal defect repair, endarterectomy,
| Company | Devices | Share |
|---|---|---|
| Teleflex Incorporated | 147 | 63% |
| Bard Peripheral Vascular, Inc. | 41 | 18% |
| Solinas Medical Inc. | 15 | 6% |
| W. L. Gore & Associates, Inc. | 12 | 5% |
| Deroyal Industries, Inc. | 10 | 4% |
| Covidien Lp | 5 | 2% |
| Stradis Medical, Llc | 3 | 1% |
| Corcym Inc. | 1 | 0% |
Company = labeler of record on GUDID. 8 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| DXZ | PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE | 194 |
| DXZ | Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene | 34 |
| GAT | SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE | 32 |
| GAW | SUTURE, NONABSORBABLE, SYNTHETIC, POLYPROPYLENE | 7 |
| OEZ | Cardiovascular Procedure Kit | 4 |
| OMR | Vessel guard or cover | 2 |
Use these as the dimensions to specify in a tender line.
234 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Cardiovascular patch, synthetic", from 8 companies. The largest labeler is Teleflex Incorporated with 63% of records.
DXZ (PATCH, PLEDGET AND INTRACARDIAC, PETP, PTFE, POLYPROPYLENE), DXZ (Patch, Pledget And Intracardiac, Petp, Ptfe, Polypropylene), GAT (SUTURE, NONABSORBABLE, SYNTHETIC, POLYETHYLENE), GAW (SUTURE, NONABSORBABLE, SYNTHETIC, POLYPROPYLENE)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add cardiovascular patch, synthetic to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.